home *** CD-ROM | disk | FTP | other *** search
- MEDICINE , Page 56New Hope
-
-
- AZT slows the onset of AIDS
-
-
- Many doctors have long suspected that the drug AZT could
- benefit the estimated 100,000 to 200,000 Americans who are
- infected with the AIDS virus but who have not yet developed
- full-blown symptoms. Last week a federal study showed that they
- were right. "This is the first clear proof that early
- intervention makes a difference," says Jerome Groopman, a
- physician with New England Deaconess Hospital in Boston. "It's
- exciting, and it's a finding of real importance."
-
- The research, conducted by a division of the National
- Institutes of Health, shows that azidothymidine, or AZT,
- dramatically slows the multiplication of the AIDS virus in
- people with mild symptoms of the disease, such as diarrhea,
- thrush (a fungal infection of the mouth), or a chronic rash.
- Until now, AZT was thought to be effective only in patients with
- more advanced cases of AIDS. Currently, the drug is the only
- medication licensed by the Food and Drug Administration as a
- treatment for the disease.
-
- Doctors and advocates for AIDS victims were elated at the
- breakthrough. Many hoped that the news would motivate people
- who are at high risk for infection -- homosexual men and
- intravenous drug users -- to get tested for the disease and seek
- counseling.
-
- But the high cost of AZT -- $7,000 to $8,000 a year -- will
- make it difficult for any but the wealthy or the well insured
- to receive the drug. Some state Medicaid programs pay for AIDS
- treatment only when the disease is far advanced. People who
- take AZT to stall the onset of AIDS may not be covered.
- Burroughs Wellcome Co., which manufactures AZT, is now seeking
- FDA clearance to use the medication in pre-AIDS patients. If the
- Federal Government permits the number of consumers to go up,
- presumably the price will come down.
-
-